Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

Steroid Therapy in Autoimmune Premature Ovarian Failure
Autoimmune Premature Ovarian Failure: A Controlled Trial of Alternate-Day Prednisone Therapy
Status: Archived
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Steroid Therapy in Autoimmune Premature Ovarian Failure
Autoimmune Premature Ovarian Failure: A Controlled Trial of Alternate-Day Prednisone Therapy
Status: Archived
Updated: 1/1/1970
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
ARREST PAD (Peripheral Arterial Disease)
The Contribution of Inflammation and Insulin Resistance to Intermittent Claudication
Status: Archived
Brigham & Women's Hospital Women's Health Center
mi
from
Chestnut Hill, MA
ARREST PAD (Peripheral Arterial Disease)
The Contribution of Inflammation and Insulin Resistance to Intermittent Claudication
Status: Archived
Updated: 1/1/1970
Brigham & Women's Hospital Women's Health Center
mi
from
Chestnut Hill, MA
Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency
Effects of Physiologic Growth Hormone Administration on Cardiovascular Risk in Subjects With Growth Hormone Deficiency Following Cure of Acromegaly
Status: Archived
Massachusetts General Hospital
mi
from
Boston, MA
Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency
Effects of Physiologic Growth Hormone Administration on Cardiovascular Risk in Subjects With Growth Hormone Deficiency Following Cure of Acromegaly
Status: Archived
Updated: 1/1/1970
Massachusetts General Hospital
mi
from
Boston, MA
Intrathecal Enzyme Replacement Therapy for Spinal Cord Compression in Mucopolysaccharidosis (MPS) I
A Study of Intrathecal Enzyme Replacement Therapy for Spinal Cord Compression in Mucopolysaccharidosis I
Status: Archived
Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center
mi
from
Torrance, CA
Intrathecal Enzyme Replacement Therapy for Spinal Cord Compression in Mucopolysaccharidosis (MPS) I
A Study of Intrathecal Enzyme Replacement Therapy for Spinal Cord Compression in Mucopolysaccharidosis I
Status: Archived
Updated: 1/1/1970
Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center
mi
from
Torrance, CA
Relation of Inflammation and Insulin Resistance to Peripheral Arterial Disease
Inflammation and Insulin Resistance in PAD
Status: Archived
Brigham & Women's Hospital Women's Health Center
mi
from
Chestnut Hill, MA
Relation of Inflammation and Insulin Resistance to Peripheral Arterial Disease
Inflammation and Insulin Resistance in PAD
Status: Archived
Updated: 1/1/1970
Brigham & Women's Hospital Women's Health Center
mi
from
Chestnut Hill, MA
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Status: Archived
Clinical Research Facility
mi
from
Phoenix, AZ
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Phoenix, AZ
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Status: Archived
Clinical Research Facility
mi
from
San Diego, CA
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
San Diego, CA
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Status: Archived
Clinical Research Facility
mi
from
Denver, CO
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Denver, CO
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Status: Archived
Clinical Research Facility
mi
from
New Haven, CT
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
New Haven, CT
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Status: Archived
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Status: Archived
Clinical Research Facility
mi
from
Evanston, IL
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Evanston, IL
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Status: Archived
Clinical Research Facility
mi
from
New Orleans, LA
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
New Orleans, LA
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Status: Archived
Clinical Research Facility
mi
from
Baltimore, MD
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Baltimore, MD
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Status: Archived
Clinical Research Facility
mi
from
St Louis, MO
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
St Louis, MO
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Status: Archived
Clinical Research Facility
mi
from
Teaneck, NJ
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Teaneck, NJ
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Status: Archived
Clinical Research Facility
mi
from
Bronx, NY
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Bronx, NY
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Status: Archived
Clinical Research Facility
mi
from
Allentown, PA
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Allentown, PA
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Status: Archived
Clinical Research Facility
mi
from
Houston, TX
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Houston, TX
Hematopoietic Stem Cell Transplantation in Patients With Antiphospholipid Syndrome
High Dose Cyclophosphamide & CAMPATH-1H With Hematopoietic Stem Cell Transplantation in Patients With Refractory Antiphospholipid Syndrome (APS): A Phase I Trial
Status: Archived
Northwestern University
mi
from
Chicago, IL
Hematopoietic Stem Cell Transplantation in Patients With Antiphospholipid Syndrome
High Dose Cyclophosphamide & CAMPATH-1H With Hematopoietic Stem Cell Transplantation in Patients With Refractory Antiphospholipid Syndrome (APS): A Phase I Trial
Status: Archived
Updated: 1/1/1970
Northwestern University
mi
from
Chicago, IL
Treatment of Depression Following Multiple Brain Tests
Medication Treatment Following Neuropsychologic, Dichotic and f-MRI Tests in Depressed Outpatients With Repeat f-MRI Following Treatment
Status: Archived
Depression Research Unit
mi
from
Philadelphia, PA
Treatment of Depression Following Multiple Brain Tests
Medication Treatment Following Neuropsychologic, Dichotic and f-MRI Tests in Depressed Outpatients With Repeat f-MRI Following Treatment
Status: Archived
Updated: 1/1/1970
Depression Research Unit
mi
from
Philadelphia, PA
Mechanisms of Insulin Resistance in Humans
Mechanisms of Insulin Resistance in Humans
Status: Archived
Carl T. Hayden VAMC
mi
from
Phoenix, AZ
Mechanisms of Insulin Resistance in Humans
Mechanisms of Insulin Resistance in Humans
Status: Archived
Updated: 1/1/1970
Carl T. Hayden VAMC
mi
from
Phoenix, AZ
Evaluate the Effect of Growth Hormone (GH) Treatment on Fibroblast Growth Factor 23, a Known Phosphaturic Agent
Evaluate the Effect of Growth Hormone (GH) Treatment on Fibroblast Growth Factor 23 (a Known Phosphaturic Agent)
Status: Archived
Children's Hospital
mi
from
Pittsburgh, PA
Evaluate the Effect of Growth Hormone (GH) Treatment on Fibroblast Growth Factor 23, a Known Phosphaturic Agent
Evaluate the Effect of Growth Hormone (GH) Treatment on Fibroblast Growth Factor 23 (a Known Phosphaturic Agent)
Status: Archived
Updated: 1/1/1970
Children's Hospital
mi
from
Pittsburgh, PA
Luveris®(Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (LH <1.2 IU/L)
A Phase IV , Multicenter, Randomized, Double-blinded, Clinical Trial to Confirm the Efficacy of the 75 IU Dose of Luveris® vs. Placebo When Administered With Follitropin Alfa for Induction of Follicular Development and Pregnancy in Hypogonadotropic Hypogonadal Women With Profound LH Deficiency, as Defined by a Baseline LH Level <1.2 IU/L.
Status: Archived
U.S. Medical Information
mi
from
Rockland, MA
Luveris®(Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (LH <1.2 IU/L)
A Phase IV , Multicenter, Randomized, Double-blinded, Clinical Trial to Confirm the Efficacy of the 75 IU Dose of Luveris® vs. Placebo When Administered With Follitropin Alfa for Induction of Follicular Development and Pregnancy in Hypogonadotropic Hypogonadal Women With Profound LH Deficiency, as Defined by a Baseline LH Level <1.2 IU/L.
Status: Archived
Updated: 1/1/1970
U.S. Medical Information
mi
from
Rockland, MA
Carnitine Levels and Carnitine Supplementation in Type I Diabetes
Correlation Between Carnitine Deficiency and Hypoglycemic Events in Type I Diabetes; Effects of Carnitine Supplementation on Hypoglycemic Events in Type I Diabetes
Status: Archived
The Children's Hospital Association
mi
from
Aurora, CO
Carnitine Levels and Carnitine Supplementation in Type I Diabetes
Correlation Between Carnitine Deficiency and Hypoglycemic Events in Type I Diabetes; Effects of Carnitine Supplementation on Hypoglycemic Events in Type I Diabetes
Status: Archived
Updated: 1/1/1970
The Children's Hospital Association
mi
from
Aurora, CO
Letrozole Treatment in Normal and GnRH Deficient Women
Letrozole Treatment in Normal and GnRH Deficient Women
Status: Archived
Massachusetts General Hospital
mi
from
Boston, MA
Letrozole Treatment in Normal and GnRH Deficient Women
Letrozole Treatment in Normal and GnRH Deficient Women
Status: Archived
Updated: 1/1/1970
Massachusetts General Hospital
mi
from
Boston, MA
Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2
Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2
Status: Archived
Stanford university Hospital and Clinics
mi
from
Stanford, CA
Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2
Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2
Status: Archived
Updated: 1/1/1970
Stanford university Hospital and Clinics
mi
from
Stanford, CA
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Status: Archived
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Status: Archived
Updated: 1/1/1970
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Insulin Sensitizers on Mitochondrial ATP Production and Mitochondrial ATP Production and Mitochondrial Protein Synthesis on Insulin Resistant Type 2 Diabetes and Obesity
The Effect of Insulin Sensitizers on Mitochondrial ATP Production and Mitochondrial ATP Production and Mitochondrial Protein Synthesis on Insulin Resistant Type 2 Diabetic and Obese People
Status: Archived
Mayo Clinic Rochester
mi
from
Rochester, MN
Insulin Sensitizers on Mitochondrial ATP Production and Mitochondrial ATP Production and Mitochondrial Protein Synthesis on Insulin Resistant Type 2 Diabetes and Obesity
The Effect of Insulin Sensitizers on Mitochondrial ATP Production and Mitochondrial ATP Production and Mitochondrial Protein Synthesis on Insulin Resistant Type 2 Diabetic and Obese People
Status: Archived
Updated: 1/1/1970
Mayo Clinic Rochester
mi
from
Rochester, MN
Exercise Training and Glucose Metabolism in Aging
Aging, Angiogenesis and Metabolic Responses to Aerobic Exercise
Status: Archived
VA Maryland Health Care System, Baltimore
mi
from
Baltimore, MD
Exercise Training and Glucose Metabolism in Aging
Aging, Angiogenesis and Metabolic Responses to Aerobic Exercise
Status: Archived
Updated: 1/1/1970
VA Maryland Health Care System, Baltimore
mi
from
Baltimore, MD
Mitochondrial Oxidation and Insulin Resistance in Burn Patients Treated With Fenofibrate
The Role of Mitochondrial Oxidation on Insulin Resistance in Burn Patients Treated With Fenofibrate
Status: Archived
Shriners Hospital for Children
mi
from
Galveston, TX
Mitochondrial Oxidation and Insulin Resistance in Burn Patients Treated With Fenofibrate
The Role of Mitochondrial Oxidation on Insulin Resistance in Burn Patients Treated With Fenofibrate
Status: Archived
Updated: 1/1/1970
Shriners Hospital for Children
mi
from
Galveston, TX
Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease
An Open Label, Four Week, Dose Escalating Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Study of CTA018 Injection in Subjects With Stage 5 Chronic Kidney Disease With Secondary Hyperparathyroidism on Hemodialysis
Status: Archived
Pines Clinical Research, Inc.
mi
from
Pembroke Pines, FL
Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease
An Open Label, Four Week, Dose Escalating Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Study of CTA018 Injection in Subjects With Stage 5 Chronic Kidney Disease With Secondary Hyperparathyroidism on Hemodialysis
Status: Archived
Updated: 1/1/1970
Pines Clinical Research, Inc.
mi
from
Pembroke Pines, FL
Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease
An Open Label, Four Week, Dose Escalating Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Study of CTA018 Injection in Subjects With Stage 5 Chronic Kidney Disease With Secondary Hyperparathyroidism on Hemodialysis
Status: Archived
Boise Kidney and Hypertension Institute
mi
from
Meridian, ID
Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease
An Open Label, Four Week, Dose Escalating Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Study of CTA018 Injection in Subjects With Stage 5 Chronic Kidney Disease With Secondary Hyperparathyroidism on Hemodialysis
Status: Archived
Updated: 1/1/1970
Boise Kidney and Hypertension Institute
mi
from
Meridian, ID
Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease
An Open Label, Four Week, Dose Escalating Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Study of CTA018 Injection in Subjects With Stage 5 Chronic Kidney Disease With Secondary Hyperparathyroidism on Hemodialysis
Status: Archived
Western New England Renal & Transplant Associates (WNERTA)
mi
from
Springfield, MA
Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease
An Open Label, Four Week, Dose Escalating Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Study of CTA018 Injection in Subjects With Stage 5 Chronic Kidney Disease With Secondary Hyperparathyroidism on Hemodialysis
Status: Archived
Updated: 1/1/1970
Western New England Renal & Transplant Associates (WNERTA)
mi
from
Springfield, MA
Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease
An Open Label, Four Week, Dose Escalating Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Study of CTA018 Injection in Subjects With Stage 5 Chronic Kidney Disease With Secondary Hyperparathyroidism on Hemodialysis
Status: Archived
Southeast Renal Research Institute
mi
from
Chattanooga, TN
Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease
An Open Label, Four Week, Dose Escalating Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Study of CTA018 Injection in Subjects With Stage 5 Chronic Kidney Disease With Secondary Hyperparathyroidism on Hemodialysis
Status: Archived
Updated: 1/1/1970
Southeast Renal Research Institute
mi
from
Chattanooga, TN
Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease
An Open Label, Four Week, Dose Escalating Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Study of CTA018 Injection in Subjects With Stage 5 Chronic Kidney Disease With Secondary Hyperparathyroidism on Hemodialysis
Status: Archived
U.S. Renal Care
mi
from
Fort Worth, TX
Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease
An Open Label, Four Week, Dose Escalating Pharmacokinetic, Pharmacodynamic, Efficacy and Safety Study of CTA018 Injection in Subjects With Stage 5 Chronic Kidney Disease With Secondary Hyperparathyroidism on Hemodialysis
Status: Archived
Updated: 1/1/1970
U.S. Renal Care
mi
from
Fort Worth, TX
Inflammation and Insulin Resistance in Rheumatoid Arthritis
Inflammation and Insulin Resistance in Rheumatoid Arthritis
Status: Archived
Vanderbilt Clinical Research Center
mi
from
Nashville, TN
Inflammation and Insulin Resistance in Rheumatoid Arthritis
Inflammation and Insulin Resistance in Rheumatoid Arthritis
Status: Archived
Updated: 1/1/1970
Vanderbilt Clinical Research Center
mi
from
Nashville, TN
Comparative Effect of Nebivolol vs. Metoprolol on Insulin Sensitivity and Fibrinolytic Balance in Metabolic Syndrome
Comparative Effect of Nebivolol vs. Metoprolol on Insulin Sensitivity and Fibrinolytic Balance in Metabolic Syndrome
Status: Archived
Vanderbilt University Medical Center
mi
from
Nashville, TN
Comparative Effect of Nebivolol vs. Metoprolol on Insulin Sensitivity and Fibrinolytic Balance in Metabolic Syndrome
Comparative Effect of Nebivolol vs. Metoprolol on Insulin Sensitivity and Fibrinolytic Balance in Metabolic Syndrome
Status: Archived
Updated: 1/1/1970
Vanderbilt University Medical Center
mi
from
Nashville, TN
Prevention of Secondary Hyperparathyroidism With Vitamin D in Stage II/III Chronic Kidney Disease
Prevention of Secondary Hyperparathyroidism With Vitamin D in Stage II/III Chronic Kidney Disease
Status: Archived
Atlanta VAMC
mi
from
Atlanta, GA
Prevention of Secondary Hyperparathyroidism With Vitamin D in Stage II/III Chronic Kidney Disease
Prevention of Secondary Hyperparathyroidism With Vitamin D in Stage II/III Chronic Kidney Disease
Status: Archived
Updated: 1/1/1970
Atlanta VAMC
mi
from
Atlanta, GA
Simvastatin With or Without Ezetimibe and Atherothrombotic Biomarker Assessment
The Effects of Ezetimibe/Simvastatin Versus Simvastatin Alone on Platelet and Inflammatory Biomarkers in Patients With the Metabolic Syndrome
Status: Archived
University of Maryland, Baltimore
mi
from
Baltimore, MD
Simvastatin With or Without Ezetimibe and Atherothrombotic Biomarker Assessment
The Effects of Ezetimibe/Simvastatin Versus Simvastatin Alone on Platelet and Inflammatory Biomarkers in Patients With the Metabolic Syndrome
Status: Archived
Updated: 1/1/1970
University of Maryland, Baltimore
mi
from
Baltimore, MD
Simvastatin With or Without Ezetimibe and Atherothrombotic Biomarker Assessment
The Effects of Ezetimibe/Simvastatin Versus Simvastatin Alone on Platelet and Inflammatory Biomarkers in Patients With the Metabolic Syndrome
Status: Archived
VA Maryland Health Care System
mi
from
Baltimore, MD
Simvastatin With or Without Ezetimibe and Atherothrombotic Biomarker Assessment
The Effects of Ezetimibe/Simvastatin Versus Simvastatin Alone on Platelet and Inflammatory Biomarkers in Patients With the Metabolic Syndrome
Status: Archived
Updated: 1/1/1970
VA Maryland Health Care System
mi
from
Baltimore, MD
Simvastatin With or Without Ezetimibe and Atherothrombotic Biomarker Assessment
The Effects of Ezetimibe/Simvastatin Versus Simvastatin Alone on Platelet and Inflammatory Biomarkers in Patients With the Metabolic Syndrome
Status: Archived
Johns Hopkins Hosp
mi
from
Baltimore, MD
Simvastatin With or Without Ezetimibe and Atherothrombotic Biomarker Assessment
The Effects of Ezetimibe/Simvastatin Versus Simvastatin Alone on Platelet and Inflammatory Biomarkers in Patients With the Metabolic Syndrome
Status: Archived
Updated: 1/1/1970
Johns Hopkins Hosp
mi
from
Baltimore, MD
Effects of Novel Fiber on Glucose Homeostasis in Individuals at Risk for Diabetes
Novel Fiber Effects on Glucose Metabolism and Insulin Sensitivity for Individuals at High Risk for Diabetes: a Randomized, Placebo-Controlled, Double-Blind, Parallel Group Clinical Trial
Status: Archived
Louisville Metabolic and Atherosclerosis Research Center
mi
from
Louisville, KY
Effects of Novel Fiber on Glucose Homeostasis in Individuals at Risk for Diabetes
Novel Fiber Effects on Glucose Metabolism and Insulin Sensitivity for Individuals at High Risk for Diabetes: a Randomized, Placebo-Controlled, Double-Blind, Parallel Group Clinical Trial
Status: Archived
Updated: 1/1/1970
Louisville Metabolic and Atherosclerosis Research Center
mi
from
Louisville, KY
Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)
A Phase 4 Randomized Multicenter Open Label Trial of Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3 or 4 Ckd Patients With Secondary Hyperparathyroidism
Status: Archived
North Shore University Health Systems
mi
from
Evanston, IL
Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)
A Phase 4 Randomized Multicenter Open Label Trial of Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3 or 4 Ckd Patients With Secondary Hyperparathyroidism
Status: Archived
Updated: 1/1/1970
North Shore University Health Systems
mi
from
Evanston, IL
Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)
A Phase 4 Randomized Multicenter Open Label Trial of Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3 or 4 Ckd Patients With Secondary Hyperparathyroidism
Status: Archived
Henry Ford Hospital
mi
from
Detroit, MI
Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)
A Phase 4 Randomized Multicenter Open Label Trial of Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3 or 4 Ckd Patients With Secondary Hyperparathyroidism
Status: Archived
Updated: 1/1/1970
Henry Ford Hospital
mi
from
Detroit, MI
Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)
A Phase 4 Randomized Multicenter Open Label Trial of Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3 or 4 Ckd Patients With Secondary Hyperparathyroidism
Status: Archived
Washington University
mi
from
St. Louis, MO
Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)
A Phase 4 Randomized Multicenter Open Label Trial of Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3 or 4 Ckd Patients With Secondary Hyperparathyroidism
Status: Archived
Updated: 1/1/1970
Washington University
mi
from
St. Louis, MO
Insulin Resistance in Pulmonary Arterial Hypertension
The Effect of Bosentan and Pioglitazone on Insulin Resistance in Pulmonary Arterial Hypertension
Status: Archived
Stanford university Hospital and Clinics
mi
from
Stanford, CA
Insulin Resistance in Pulmonary Arterial Hypertension
The Effect of Bosentan and Pioglitazone on Insulin Resistance in Pulmonary Arterial Hypertension
Status: Archived
Updated: 1/1/1970
Stanford university Hospital and Clinics
mi
from
Stanford, CA
A Study for Pre-Diabetic Patients With Cholesterol Lowering Drugs
Effects of Simvastatin and Rosiglitazone Combination in Patients With the Metabolic Syndrome.
Status: Archived
University of Chicago
mi
from
Chicago, IL
A Study for Pre-Diabetic Patients With Cholesterol Lowering Drugs
Effects of Simvastatin and Rosiglitazone Combination in Patients With the Metabolic Syndrome.
Status: Archived
Updated: 1/1/1970
University of Chicago
mi
from
Chicago, IL
Estrogen Dosing in Turner Syndrome: Pharmacology and Metabolism
Estrogen Dosing in Turner Syndrome:Pharmacology & Metabolism
Status: Archived
Nemours Children's Clinic
mi
from
Jacksonville, FL
Estrogen Dosing in Turner Syndrome: Pharmacology and Metabolism
Estrogen Dosing in Turner Syndrome:Pharmacology & Metabolism
Status: Archived
Updated: 1/1/1970
Nemours Children's Clinic
mi
from
Jacksonville, FL
Estrogen Dosing in Turner Syndrome: Pharmacology and Metabolism
Estrogen Dosing in Turner Syndrome:Pharmacology & Metabolism
Status: Archived
Thomas Jefferson Hospital
mi
from
Philadelphia, PA
Estrogen Dosing in Turner Syndrome: Pharmacology and Metabolism
Estrogen Dosing in Turner Syndrome:Pharmacology & Metabolism
Status: Archived
Updated: 1/1/1970
Thomas Jefferson Hospital
mi
from
Philadelphia, PA
Adrenal Insufficiency in Septic Shock
An Open-label, Prospective, Randomized, Controlled Clinical Trial of the Use of Reduced Duration Versus Standard Duration Steroid Replacement Therapy for Acute Adrenal Insufficiency in Patients With Septic Shock
Status: Archived
Houston Methodist Hospital
mi
from
Houston, TX
Adrenal Insufficiency in Septic Shock
An Open-label, Prospective, Randomized, Controlled Clinical Trial of the Use of Reduced Duration Versus Standard Duration Steroid Replacement Therapy for Acute Adrenal Insufficiency in Patients With Septic Shock
Status: Archived
Updated: 1/1/1970
Houston Methodist Hospital
mi
from
Houston, TX